Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
-Topline data from the Phase II study for the treatment of diabetes…
New Seat Belt Legislation Takes Effect — Kwoon Chung Bus Fully Compliant Strengthening Passenger and Road Safety through a Safety‑First Culture and AI Smart Driving Management Systems
HONG KONG, Jan. 25, 2026 /PRNewswire/ — With the Hong Kong Government’s…